Cargando…
Neuroprotection and Axonal Regeneration Induced by Bone Marrow Mesenchymal Stromal Cells Depend on the Type of Transplant
Mesenchymal stromal cell (MSC) therapy to treat neurodegenerative diseases has not been as successful as expected in some preclinical studies. Because preclinical research is so diverse, it is difficult to know whether the therapeutic outcome is due to the cell type, the type of transplant or the mo...
Autores principales: | Norte-Muñoz, María, Lucas-Ruiz, Fernando, Gallego-Ortega, Alejandro, García-Bernal, David, Valiente-Soriano, Francisco J., de la Villa, Pedro, Vidal-Sanz, Manuel, Agudo-Barriuso, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600074/ https://www.ncbi.nlm.nih.gov/pubmed/34805178 http://dx.doi.org/10.3389/fcell.2021.772223 |
Ejemplares similares
-
Interplay between mesenchymal stromal cells and the immune system after transplantation: implications for advanced cell therapy in the retina
por: Norte-Muñoz, María, et al.
Publicado: (2023) -
Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas
por: Norte-Muñoz, María, et al.
Publicado: (2022) -
Ly6c as a New Marker of Mouse Blood Vessels: Qualitative and Quantitative Analyses on Intact and Ischemic Retinas
por: Martínez-Carmona, Marina, et al.
Publicado: (2021) -
Axonal Regeneration by Glycosaminoglycan
por: Sakamoto, Kazuma, et al.
Publicado: (2021) -
Identifying specific RGC types may shed light on their idiosyncratic responses to neuroprotection
por: Vidal-Sanz, Manuel, et al.
Publicado: (2015)